Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Microwave Ablation System Monitors Tissue Destruction

By HospiMedica International staff writers
Posted on 01 Oct 2009
A microwave coagulation-ablation system measures real-time changes in temperature and power absorption in the ablation zone.

The MedWaves AveCure system enables surgeons and interventional radiologists to safely treat soft tissue problems, such as tumors in the liver and lung, using thermal coagulation-ablation. More...
The system includes a microwave generator and a combination probe and antenna, and requires no cooling, no irrigation, and no return pad. The sterile single-patient-use probes monitor temperature and power feedback from the probe itself and from nearby tissue to intelligently control the microwave power delivered to the ablation zone. By utilizing and displaying dynamic changes in temperature and power, the system safely and efficiently ablates small or large zones, using far less power. The same feedbacks are available for the user to manage the ablation process with confidence. Multiple systems can concurrently apply energy to treat larger lesions or shape the ablation zone to fit lesion boundaries.

The MedWaves AveCure system is under development by MedWaves (San Diego, CA, USA), and has been recognized as an investigational device; the company is also developing smaller diameter microwave probes/antennae with focused microwave fields to destroy small metastatic lesions in liver, lung, and other organs safely and effectively.

Microwave ablation is the most recent development in the field of tumor ablation. The technique allows for flexible approaches to treatment, including percutaneous, laparoscopic, and open surgical access. With imaging guidance, the tumor is localized, and a thin (14.5-gauge) microwave antenna is placed directly into the tumor. A microwave generator then emits an electromagnetic wave through the exposed, noninsulated portion of the antenna. Electromagnetic microwaves agitate water molecules in the surrounding tissue, producing friction and heat, thus inducing cellular death via coagulation necrosis.

The main advantages of microwave technology, when compared with existing thermoablative technologies, include consistently higher intratumoral temperatures, larger tumor ablation volumes, faster ablation times, and an improved convection profile. Further benefits of microwave ablation include less pain and discomfort during percutaneous outpatient procedures and significantly reduced anesthetic dosage requirements, when compared to radiofrequency (RF) ablation.

Related Links:

MedWaves



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.